Feature Channels: Infectious Diseases

Filters close
Released: 13-May-2024 9:05 AM EDT
Negotiations for a Global Pandemic Agreement Extended
Wildlife Conservation Society

Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.

Newswise: 3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
Released: 9-May-2024 5:05 PM EDT
3i Symposium Inspires Interdisciplinary Insights in Immunology, Inflammation, and Infection
University of Utah Health

Over 150 researchers from across the University of Utah gathered to form new connections and share groundbreaking research on topics from antibiotic resistance to autoimmune diseases.

   
Newswise: An Entirely New COVID-Related Syndrome
Released: 9-May-2024 12:05 PM EDT
An Entirely New COVID-Related Syndrome
University of California San Diego

A group of UC San Diego researchers, centered at UC San Diego's Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.

Released: 9-May-2024 10:00 AM EDT
Shruti Mehta, Infectious Disease Epidemiologist, Named Chair of Johns Hopkins Bloomberg School of Public Health Epidemiology Department
Johns Hopkins Bloomberg School of Public Health

Shruti Mehta, PhD, MPH, has been named The Dr. Charles Armstrong Chair in Epidemiology and Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, effective June 1.

Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

Released: 26-Apr-2024 10:05 AM EDT
New Tool Helps Identify Babies at High-Risk for RSV
Vanderbilt University Medical Center

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.

18-Apr-2024 4:05 PM EDT
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
Ann and Robert H. Lurie Children's Hospital of Chicago

A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.

Newswise: Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
Released: 23-Apr-2024 3:05 AM EDT
Vaccinologists Keith Klugman and Shabir Madhi awarded Sabin’s Prestigious Gold Medal
University of the Witwatersrand, Johannesburg

The Sabin Vaccine Institute presented the Albert B. Sabin Gold Medal to physician-researchers Keith Klugman and Shabir Madhi.

Released: 22-Apr-2024 9:05 AM EDT
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Michigan Medicine - University of Michigan

America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won’t touch, a new study finds.

Newswise: From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
Released: 15-Apr-2024 9:05 PM EDT
From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
University of South Australia

New research has given insight into the resilience and recovery of businesses in two South Australian regions following a major bushfire event and disruptions caused by the COVID-19 pandemic.

Not for public release

This news release is embargoed until 15-Apr-2024 5:00 PM EDT Released to reporters: 9-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
4.14858